Clinical Trial 54546

Newport Beach, CA 92660


Summary:

Living With Narcolepsy?

The aim of this study is to quantify the change in blood pressure when participants with narcolepsy treated with high-sodium oxybate are transitioned to XYWAV, a low-sodium oxybate. The results of this study may provide health care providers (HCPs), patients, and payers with important new information regarding BP changes related to differences in sodium content between available oxybates for the treatment of narcolepsy

To qualify, you must:

  • Be 18 to 70 years of age.
  • Have a documented diagnosis of Type 1 or Type 2 narcolepsy.
  • Have been receiving a dose of high-sodium oxybate (eg, XYREM) of 6 to 9 g/night (inclusive) for a minimum of 6 consecutive weeks prior to screening.
  • If female, must not be pregnant or breastfeeding.

*Other criteria also apply


Qualified Participants May Receive:

Compensation for time and travel


Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.